A new weapon will to combat excess body weight.
The UK's National Institute for Health and Care Excellence (NICE) has published a draft recommendation for the use (and funding by the NHS) of semaglutide to aid weight loss in adults with at least one obesity-related condition (not necessarily diabetes mellitus). 2) and with a BMI ≥ 35 kg/m², and, in certain cases, in people with a BMI in the range of 30–34.9 kg/m².
In addition, the BMI threshold was set slightly lower (by 2.5 kg/m²) for black people or South Asian, Chinese and Caribbean families - in line...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
